These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20451282)

  • 21. Pediatric post-transplant metabolic syndrome: new clouds on the horizon.
    Nobili V; de Ville de Goyet J
    Pediatr Transplant; 2013 May; 17(3):216-23. PubMed ID: 23496113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
    Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L
    Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving long-term outcomes after liver transplantation.
    Charlton MR
    Clin Liver Dis; 2014 Aug; 18(3):717-30. PubMed ID: 25017085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term management after liver transplantation: primary care physician versus hepatologist.
    Heller JC; Prochazka AV; Everson GT; Forman LM
    Liver Transpl; 2009 Oct; 15(10):1330-5. PubMed ID: 19790168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early development of metabolic syndrome in patients subjected to lung transplantation.
    Savioli G; Surbone S; Giovi I; Salinaro F; Preti P; Meloni F; Oggionni T; Perlini S
    Clin Transplant; 2013; 27(3):E237-43. PubMed ID: 23414418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation.
    Van Wagner LB; Baker T; Ahya SN; Norvell JP; Wang E; Levitsky J
    J Hepatol; 2009 Nov; 51(5):874-80. PubMed ID: 19643508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and metabolic syndrome: potential benefit from specific nutritional components.
    Abete I; Goyenechea E; Zulet MA; Martínez JA
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management of the liver transplant recipient.
    Stravitz RT; Carl DE; Biskobing DM
    Clin Liver Dis; 2011 Nov; 15(4):821-43. PubMed ID: 22032531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of obesity on renal transplant outcomes.
    Armstrong KA; Campbell SB; Hawley CM; Johnson DW; Isbel NM
    Nephrology (Carlton); 2005 Aug; 10(4):405-13. PubMed ID: 16109090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAFLD recurrence in liver transplant recipients.
    Dureja P; Mellinger J; Agni R; Chang F; Avey G; Lucey M; Said A
    Transplantation; 2011 Mar; 91(6):684-9. PubMed ID: 21248661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing the risks of cardiovascular disease in liver allograft recipients.
    Mells G; Neuberger J
    Transplantation; 2007 May; 83(9):1141-50. PubMed ID: 17496526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and NASH.
    Marchesini G; Marzocchi R
    Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome in transplant patients: an academic or a health burden?
    Sorice GP; Muscogiuri G; Mezza T; Prioletta A; Giaccari A
    Transplant Proc; 2011; 43(1):313-7. PubMed ID: 21335212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of appropriate patients for cardiometabolic risk management.
    Peters AL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-liver transplant obesity and diabetes.
    T D Correia MI; Rego LO; Lima AS
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):457-60. PubMed ID: 12806221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
    Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Charlton MR
    Am J Transplant; 2010 Jun; 10(6):1420-7. PubMed ID: 20486907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome in transplant patients: an updating point of view.
    Sorice GP; Di Pizio L; Sun VA; Schirò T; Muscogiuri G; Mezza T; Cefalo CM; Prioletta A; Pontecorvi A; Giaccari A
    Minerva Endocrinol; 2012 Sep; 37(3):211-20. PubMed ID: 22766888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.